InvestorsHub Logo
Followers 3
Posts 185
Boards Moderated 0
Alias Born 05/19/2008

Re: None

Thursday, 07/08/2010 6:15:29 PM

Thursday, July 08, 2010 6:15:29 PM

Post# of 19499
First it was Imagin Molecular Corporation Acquires an Investment Position in Positron Corporation Currently Valued at $35 Million

and now its huge increase in demand as healthcare grows

Positron's award-winning, cardiac optimized PET scanner, the Attrius(TM), is the only advanced, dedicated, cost-effective PET scanner in the marketplace. The introduction of the Attrius(TM) last year has generated excitement throughout the cardiac molecular imaging industry. Facilitated by the increase in reimbursement for cardiac PET and an industry-wide movement to better and more efficient medical imaging, Positron's Attrius(TM) has seen unprecedented interest and sales. As a result of the recent sales, Positron has met its six month projections and has to increase production earlier than previous estimations. Based on Positron's current sales and a more robust pipeline, the Company believes that they will surpass 2010 and 2011 targets of approximately 70 systems in the next 18 months.

This company should be getting alot more new investors in through the door soon.